Idera Pharmaceuticals Presents Preclinical Data in Lupus Disease Models on Use of Novel Class of Antagonists for Toll-Like Receptors
Idera Pharmaceuticals Presents Preclinical Data in Lupus Disease Models on Use of Novel Class of Antagonists for Toll-Like Receptors
Feb 12, 2007
Click here to access PDF press release.